2024-03-29T06:33:14Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_A5AEE20D374F
2024-03-23T02:47:35Z
openaire
documents
urnserval
serval:BIB_A5AEE20D374F
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study.
10.1016/j.ejca.2021.08.026
000701900000024
34536946
http://dx.doi.org/10.1016/j.ejca.2021.08.026
Da Silva Lopes
A.M.
author
Colomer-Lahiguera
S.
author
Mederos Alfonso
N.
author
Aedo-Lopez
V.
author
Spurrier-Bernard
G.
author
Tolstrup
L.K.
author
Pappot
H.
author
Aspeslagh
S.
author
Rogiers
A.
author
Neyns
B.
author
Haanen
J.B.
author
Mitchell
S.A.
author
Addeo
A.
author
Michielin
O.
author
Eicher
M.
author
article
2021-11
European journal of cancer
1879-0852
0959-8049
journal
157
225-237
Consensus
Delphi Technique
Drug Monitoring/standards
Drug-Related Side Effects and Adverse Reactions/diagnosis
Drug-Related Side Effects and Adverse Reactions/immunology
Humans
Immune Checkpoint Inhibitors/adverse effects
Neoplasms/drug therapy
Neoplasms/immunology
Patient Reported Outcome Measures
Prospective Studies
Severity of Illness Index
Delphi consensus
Immune checkpoint inhibitors
PRO-CTCAE™
Patient-reported outcomes
Symptomatic immune-related adverse events
eng
60_published
true
peer-reviewed
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_A5AEE20D374F
https://serval.unil.ch/resource/serval:BIB_A5AEE20D374F.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_A5AEE20D374F3
Creative Commons : Attribution 4.0 International